SlideShare une entreprise Scribd logo
1  sur  44
Télécharger pour lire hors ligne
An Overview
    2011
              1
Your presentation today


     Pharmalink 
     Profile & Capabilities
     Global Regulatory Experience
     Project Experience – Case Studies
     Additional Capabilities 
     Summary
1. Who we are
Who we are


    Founded in UK in 1998
    Privately held
    Leading independent Regulatory Affairs 
    Specialist
    Offices in US, Europe, India and Asia‐Pacific
    155 Staff as of January 2011
    Large, proprietary network of freelance RA 
    professionals worldwide
Who we work with

    18 of top 20 healthcare companies 
    Large pharmaceutical multinationals
    Consumer Health organizations and divisions
    Biotechnology & new technology
    Clinical research organizations
    Medical device companies
    Generic companies
    Start‐up ventures
    Virtual companies
Consumer Profile
                               Pharma

                               Biotech

                        Medical device

                      Consumer Health

                             Veterinary

                              Generics

                   Nutraceuticals/Other
2. What we can we help with
What we can help with


     Small to large scale projects 
     Domestic, international and multinational 
     projects
     Short to long term projects
     Interim regulatory staffing needs
     Assistance at all stages of regulatory lifecycle
What we can help with

                                      Non‐clinical

                             Clinical Development
 D ru
        g Di               Pre‐Submission Activity
             scov
                  e   ry
                               Filing / Submission

                                         Approval

                                  Product Launch

                                    Post‐Approval
RA Solutions that fit your business

 REGULATORY                   Regulatory Strategy         Clinical                    Advertising & 
                                                                                      Promotion/Labeling
 SERVICES                     Regulatory agency           Preparation of
                              meetings                    CTD Module 2 & 5            USPI/PLR/SPC/CDS
                              Filing strategy             Review of protocols &       User testing
                              Response to agency          CSRs                        Packaging
                              queries                     CTA preparation
                              Advisory Committee          Review of IBs
                              preparation                                             Regulatory Operations
 CMC & Manufacturing                                      IRB/EC documentation
                              Scientific Advice
 Compliance                                               Orphan indication           CTD/eCTD/dossier 
                              Lifecycle management                                    preparation
                                                          Pediatric development
 Gap analysis & remediation   Input from Subject Matter   plans                       Submission advice
                              Experts
 Preparation of                                           Amendments                  Translation service
 CTD Module 2 & 3                                         Medical writing
                              Filing Expertise
 DMF preparation                                          GCP audit                   Non‐clinical
 Validation                   IND/IMPD
 TPM site identification      Original NDA/MAA            Postmarketing Maintenance   Preparation of
 Contract QP                  ANDA                                                    CTD Module 2 & 4
 Import documentation and                                 sNDA/variations             Review of toxicology & 
                              BLA                                                     pharmacology studies
 licensing                                                Annual  Reporting
                              510K/PMA
 GLP/GMP audit                                            Postmarketing Commitments
 Pre‐approval inspections                                 Safety reporting eg PSUR
RA Solutions that fit your business


   A Regulatory Affairs team for
   all your regulatory needs

     Junior consultants to Subject Matter Experts 
     Generalists to specialists
     Assistance with projects of any scale and 
     length
     On‐site or remote working on Domestic, 
     International, and Multinational assignments
How we work


    Project are served by appropriate experience
    – 1 yr to 30+ yr depending on requirements
    – Mainstream or specialized experienced
    – Industry and/or Agency expertise

    Senior Regulatory Managers assisted by 
    junior level staff for data intensive work
3. Global Regulatory Experience
Global experience

   Our consultants have experience in the 
   following regions:

    Europe (EU, Switzerland, Norway, Iceland)
    Middle East and Africa
    North America and Canada
    Central America and Caribbean Community
    Latin America
    Central & Eastern European states
    Australia & New Zealand
Global Pharmalink Offices
Cambridge, MA
Short Hills, NJ
King of Prussia, PA   Maidenhead, UK



                                                Singapore
 San Francisco, CA



                                       Mumbai, India
Hartford, CT
Washington, DC
New York, NY
Durham, NC
Pharmalink Affiliate Network




    LOCAL REGULATORY AFFAIRS WORLDWIDE
Pharmalink Affiliate Network


     Access to local Regulatory Affairs
     expertise when and where  you need it.
     The best Regulatory Affairs professionals in every 
     continent.
     Covering every market from Argentina to Zambia.
     Leading local consultants who:
     – understand the culture
     – will ensure your requirements are met
     – save you time and money.
Pharmalink Affiliate Network


              EUROPE


 AUSTRIA  |  BELGIUM  |  CYPRUS  |  CZECH REPUBLIC  |  DENMARK  | FINLAND
   FRANCE  |  GERMANY  |  GREECE  |  IRELAND  |  ITALY  |  NETHERLANDS
PORTUGAL  |  SPAIN  |  SWEDEN  |  SWITZERLAND  |  TURKEY |  UK (GLOBAL HQ)
Pharmalink Affiliate Network


            ME‐NA
Pharmalink Affiliate Network




                                                     AFRICA


  ANGOLA  |  BOTSWANA  |  DEMOCRATIC REPUBLIC OF CONGO  |  LESOTHO
         MADAGASCAR  |  MALAWI  |  MAURITIUS  |  MOZAMBIQUE
NAMIBIA | SOUTH AFRICA  |  SWAZILAND  |  TANZANIA  |  ZAMBIA  |  ZIMBABWE
Pharmalink Affiliate Network

                  EASTERN
                   EUROPE


 ALBANIA  |  AZERBAIJAN  |  BOSNIA & HERZEGOVINA  |  BULGARIA  |  CROATIA
               ESTONIA  |  GEORGIA  |  HUNGARY  |  KAZAKHSTAN
KOSOVO  |  MACEDONIA  |  MOLDOVA  |  MONTENEGRO  |  POLAND  |  ROMANIA
    RUSSIA  |  SERBIA  |  SLOVAKIA  |  SLOVENIA  |  UKRAINE  |  UZBEKISTAN
Pharmalink Affiliate Network



        ASIA PAC



              AUSTRALIA  |  CHINA  |  HONG KONG  |  INDIA
   JAPAN  |  MALAYSIA  |  NEW ZEALAND  |  PHILIPPINES  |  SINGAPORE
                      SOUTH KOREA  |  THAILAND
Pharmalink Affiliate Network




                                     NORTH AMERICA


                                CANADA
  UNITED STATES:  NJ (US HQ) |  MA  |  CT  |  NY  |  PA  |  NC  |  CA  |  DC
Pharmalink Affiliate Network

ARGENTINA  |  ARUBA  |  BELIZE  |  BRAZIL  |  CHILE  |  COLOMBIA |  COSTA RICA
    DOMINICAN REPUBLIC  |  ECUADOR  |  EL SALVADOR  |  GUATEMALA
              HONDURAS  |  JAMAICA  |  MEXICO  |  NICARAGUA
 PANAMA  |  PARAGUAY  |  PERU  |  PUERTO RICO  |  TRINIDAD  |  VENEZUELA
4. Case Studies
Case Study 1

   Major regulatory compliance project
   CLIENT    A major pharmaceutical company based in Europe.
   PROJECT A large compliance project.
   OBJECTIVE Review all European‐registered licenses and bring into 
             compliance with current manufacturing site practices.
   SOLUTION Pharmalink provided a dedicated team of regulatory affairs 
             specialists to work on the project for 3 years.

   One of the key advantages that Pharmalink was able to bring to the 
   project was the ability to adjust the number of consultants working on  
   the project to fit the client’s needs and hit every deadline whilst 
   always maintaining the level of quality.
Case Study 1

   Project Details
     Consultants reviewed registered details against manufacturing site 
     documents, highlighting compliance issues.
     Consultants worked with site QA departments in preparing 
     remediation plans for each license.
     Over 600 licenses were reviewed and each phase of the project 
     was delivered to the client’s timelines.
     Pharmalink’s staff exceeded the client’s expectations on each 
     phase of the defined project, resulting in the client engaging 
     Pharmalink to prepare all of the Variations and submit to all EU
     agencies in order to bring the product licenses into
     compliance.
Case Study 2

   Biosimilar Product Review

   CLIENT    A major pharmaceutical company based in Europe.
   PROJECT   Review and update of a Module 3 and Quality Overall 
             Summary for a Biosimilar product in preparation for one of 
             the first European submissions of its type.
   OBJECTIVE Document submission.
             Speed to market was of high priority to the client.
   SOLUTION Pharmalink  was able to turn to one of its experienced 
             consultants with a track record specifically with the biotech 
             product in question.
Case Study 2

   Project Details
     The consultant reviewed and updated submission documents and 
     provided a pragmatic corrective action listing whilst preparing key parts of 
     the filing.
     The consultant added value by preparing a risk analysis alongside the 
     required output, thus ensuring that the client was aware of potential 
     issues once the filing was undertaken.
     Work delivered to the client less than a month after the documents were 
     received by Pharmalink.
     Pharmalink completed the task by reviewing the project with the client, 
     providing an online facility to feedback on the experience and ensure a 
     satisfactory service, at no cost to the client.
     The client submitted the documentation with understanding
     of the road ahead.
Case Study 3

   Multinational clinical trial sponsor & Clinical 
   Research Organization
    CLIENT     Sponsor and CRO.
    PROJECT    Provide regulatory support for a clinical trial including new 
               submissions for the trial in multiple markets.
    OBJECTIVE Submit the clinical trial in multiple locations in a timely 
              manner to allow trial initiation.
    SOLUTION Pharmalink provided consultants with valuable local 
              knowledge to add to the regulatory intelligence of submissions 
              in each market.
   This project was a testament to the lengths to which the team
   went to understand the brief and work with the client
   to achieve their goals.
Case Study 3

   Project Details
   Multinational program ‐ 9 markets
   – Europe  FR, UK, DE, PL
   – Eastern Europe Russia, Ukraine
   – Middle East  Egypt, Israel
   – Asia  India
      The challenge was to guide a US‐based sponsor through the 
      regulatory procedures and processes, different in all markets, 
      whilst work with multiple vendors in areas such as safety 
      reporting, ethics submissions and so forth.
      Pharmalink fulfilled the requirements and submissions completed 
      to date have been filed according to the planned schedule.
Case Study 4

   Global Product Compliance Project
   Large Pharmaceutical Company
   CLIENT    Top 10 Pharma Company.
   PROJECT   Since 2004, Pharmalink Consulting have been successfully 
             performing a large‐scale Global Quality Compliance program for a 
             company, covering approximately 1400 Quality Dossiers 
             worldwide.
   OBJECTIVE Short term – get product moving around Europe again.
             Long term  – bring all dossiers and licenses up to date providing 
             sustainable compliance.
   SOLUTION The team that Pharmalink Consulting assembled has successfully 
             driven all key stages of the compliance process including:
             – Quality Dossier collection and collation into
                 CTD format
             – CMC Compliance Assessment
             – Product Remediation
Case Study 4

   Project Details
     Dossiers Collected
     270
     Dossiers Collated
     270
     Compliance Assessments Performed
     270 (10% TPM)
     Remediation Packages Prepared
     564
     Markets
     AT, BE, BU, CH, CY, CZ, DE, DK, EE, EL,ES, FI, FR, HU, IE, IS,  IT, LT,   
     LV, MT, NL, NO,  PL, PO, RO, SE, SK, UK
Case Study 4

   Project Details
     Throughout the compliance project in Europe, the Company was forced to 
     halt product shipment until gap analysis was completed. This put
     enormous pressure on the team, yet the impact on product shipments 
     remained minimal.
     Various stages of the compliance process were performed remotely from 
     the client, across the Pharmalink offices in North America, Europe and 
     Asia. All objectives and milestones were successfully achieved ahead of 
     target dates.
     The Pharmalink team reached 45 in number at the height of the activity 
     but remained flexible dependent on the workload so were able to adjust 
     accordingly. Pharmalink was able to offer office facilities for the purposes 
     of the project.
     The resulting completion of the European section of the project meant a 
     satisfied client who has continued to employ Pharmalink for regulatory 
     activities across multiple sites in Europe and the United States.
5. Additional Capabilities
Permanent Staffing

   Pharmalink Consulting, the regulatory affairs 
   specialists since 1998, introduces a unique 
   regulatory recruitment solution
    Pharmalink has unrivalled access to permanent 
       regulatory affairs candidates throughout the industry.
    All of our candidates have been interviewed by Senior 
       Regulatory Affairs professionals familiar with client 
       needs.
    We can offer optional interim staffing by one of our 
       regulatory affairs consultants while we identify
            your ideal permanent employee.
Permanent Staffing

 The Pharmalink Permanent Solution 6 Step Plan
  STEP 1        STEP 2           STEP 3           STEP 4          STEP 5          STEP 6
                                 [optional]

  You           Contact          Pharmalink       We research     Pharmalink      Following 
  identify a    Pharmalink,      can provide      our             provides a      selection, 
  permanent     where an         an               extensive       selection of    your new 
  recruitment   experienced      experienced      portfolio of    chosen          member
  need          regulatory       consultant to    regulatory      candidates      of staff 
                affairs          act as an        affairs         for you to      commences 
                professional     interim          professionals   meet and        role
                will discuss     member           who have        consider
                your             of staff while   previously 
                requirement      we identify      been 
                and take a       your ideal       screened and 
                detailed brief   permanent        vetted 
                                 employee
What else can we offer you?

     Resource backup and alternative, flexible 
     ways of working from regional hubs
     Local knowledge on a global scale
     High Quality Translation Service in 100+ 
     Languages
     A company accredited with QMS ISO 9001
     A company accredited with IIP status
     Recently completed a $2.4 million investment 
     program
     Electronic publishing ‐ eSubmissions
6. Summary
Our offering in summary


   1.   We have demonstrable capability and 
        experience with large scale multi‐product, 
        multi‐national regulatory projects on 
        behalf of Top‐20 healthcare companies.
        Our familiarity with such sizeable projects 
        provides our clients with assurance that 
        the desired results can be achieved for any 
        project of any size.
Our offering in summary


   2.   Our global regulatory teams are comprised 
        of consultants with a wide range of skills 
        and levels of experience.
        This allows us to be able to meet client 
        requirements while ensuring that costs are 
        kept to a minimum by using the right level 
        of consultant for the various tasks.
Our offering in summary


   3.   The infrastructure, both in terms of systems 
        and people, that we have established and in 
        which we have invested, underpins our 
        ability to undertake projects of varying 
        scale.
        We have a purpose‐built, centrally‐managed 
        IT network for all of our offices worldwide. 
        This will ensure peace of mind as we are able 
        to segregate and secure individual company 
        data while allowing for flexible access.
Our offering in summary


   4.   Whilst Pharmalink Consulting is now a 
        multi‐national consultancy that is 
        recognized as a global leader in Regulatory 
        Affairs, we remain nimble and flexible to 
        react to our clients’ often urgent 
        requirements.
Thank you




                               USA:  + 1 800 434 5808
SHORT HILLS, NJ   |   CAMBRIDGE, MA   |   HARTFORD, CT   |   MANHATTAN, NY   |   KING OF PRUSSIA, PA
                       DURHAM, NC   |   SAN FRANCISCO, CA   |   WASHINGTON, DC 

                                UK:  + 44 1628 860300
                                     MAIDENHEAD, BERKSHIRE

                             INDIA:  + 91 22 4030 9595
                                             MUMBAI

                           SINGAPORE:  + 65 6408 0515

Contenu connexe

Tendances

Lsl Bio Pharm Linkedin 04 09a
Lsl Bio Pharm Linkedin 04 09aLsl Bio Pharm Linkedin 04 09a
Lsl Bio Pharm Linkedin 04 09aandrewjroche
 
BCG Overview Of Services And Value Propositions 2010
BCG Overview Of Services And Value Propositions 2010BCG Overview Of Services And Value Propositions 2010
BCG Overview Of Services And Value Propositions 2010chalverson
 
Presentation China And Usa July 2011
Presentation   China And Usa July 2011Presentation   China And Usa July 2011
Presentation China And Usa July 2011roeandjoe
 
Question Summary Of Responses
Question Summary Of ResponsesQuestion Summary Of Responses
Question Summary Of Responseslegal5
 
Pharma And Biotech Brochure 2009
Pharma And Biotech Brochure 2009Pharma And Biotech Brochure 2009
Pharma And Biotech Brochure 2009tseener
 
How User Experience Design and Human Factors Engineering can Accelerate Produ...
How User Experience Design and Human Factors Engineering can Accelerate Produ...How User Experience Design and Human Factors Engineering can Accelerate Produ...
How User Experience Design and Human Factors Engineering can Accelerate Produ...Greenlight Guru
 
Silence Therapeutics Unaudited Preliminary Results 2011
Silence Therapeutics Unaudited Preliminary Results 2011Silence Therapeutics Unaudited Preliminary Results 2011
Silence Therapeutics Unaudited Preliminary Results 2011Silence Therapeutics
 
Pharmi Med Ltd Brochure
Pharmi Med Ltd BrochurePharmi Med Ltd Brochure
Pharmi Med Ltd BrochureADNAN ASHFAQ
 
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIthermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIfinance40
 

Tendances (15)

Manoj_Resume1
Manoj_Resume1Manoj_Resume1
Manoj_Resume1
 
Kvs Company Overview 28082011
Kvs Company Overview 28082011Kvs Company Overview 28082011
Kvs Company Overview 28082011
 
Lsl Bio Pharm Linkedin 04 09a
Lsl Bio Pharm Linkedin 04 09aLsl Bio Pharm Linkedin 04 09a
Lsl Bio Pharm Linkedin 04 09a
 
BioDuro
BioDuro BioDuro
BioDuro
 
BCG Overview Of Services And Value Propositions 2010
BCG Overview Of Services And Value Propositions 2010BCG Overview Of Services And Value Propositions 2010
BCG Overview Of Services And Value Propositions 2010
 
Presentation China And Usa July 2011
Presentation   China And Usa July 2011Presentation   China And Usa July 2011
Presentation China And Usa July 2011
 
Priyank _ Regulatory
Priyank _ RegulatoryPriyank _ Regulatory
Priyank _ Regulatory
 
Question Summary Of Responses
Question Summary Of ResponsesQuestion Summary Of Responses
Question Summary Of Responses
 
Pharma ready ectd
Pharma ready ectdPharma ready ectd
Pharma ready ectd
 
Pharma And Biotech Brochure 2009
Pharma And Biotech Brochure 2009Pharma And Biotech Brochure 2009
Pharma And Biotech Brochure 2009
 
How User Experience Design and Human Factors Engineering can Accelerate Produ...
How User Experience Design and Human Factors Engineering can Accelerate Produ...How User Experience Design and Human Factors Engineering can Accelerate Produ...
How User Experience Design and Human Factors Engineering can Accelerate Produ...
 
Silence Therapeutics Unaudited Preliminary Results 2011
Silence Therapeutics Unaudited Preliminary Results 2011Silence Therapeutics Unaudited Preliminary Results 2011
Silence Therapeutics Unaudited Preliminary Results 2011
 
Pharmi Med Ltd Brochure
Pharmi Med Ltd BrochurePharmi Med Ltd Brochure
Pharmi Med Ltd Brochure
 
Progamma Us
Progamma UsProgamma Us
Progamma Us
 
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIthermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
 

En vedette

How To Land A Job In Product Management (Product Camp Summer 2016)
How To Land A Job In Product Management (Product Camp Summer 2016)How To Land A Job In Product Management (Product Camp Summer 2016)
How To Land A Job In Product Management (Product Camp Summer 2016)Dan Corbin
 
The Glass is Half FULL
The Glass is Half FULLThe Glass is Half FULL
The Glass is Half FULLMartafy!
 
Out of the Fishbowl
Out of the FishbowlOut of the Fishbowl
Out of the FishbowlMartafy!
 
Implications of MIFIDII - The Regulator’s View (Alberto Garcia)
Implications of MIFIDII - The Regulator’s View (Alberto Garcia)Implications of MIFIDII - The Regulator’s View (Alberto Garcia)
Implications of MIFIDII - The Regulator’s View (Alberto Garcia)CBS Competitiveness Platform
 
The Next Generation of Immersive, Online Brand Building
The Next Generation of Immersive, Online Brand BuildingThe Next Generation of Immersive, Online Brand Building
The Next Generation of Immersive, Online Brand BuildingMartafy!
 
UX Kick Start - Start Your Mobile Project Off On The Right Foot
UX Kick Start - Start Your Mobile Project Off On The Right FootUX Kick Start - Start Your Mobile Project Off On The Right Foot
UX Kick Start - Start Your Mobile Project Off On The Right FootMark Kraemer
 
Vidensmodellering & Digitalisering (Bodil Nistrup Madsen & Hanne Erdman Thomsen)
Vidensmodellering & Digitalisering (Bodil Nistrup Madsen & Hanne Erdman Thomsen)Vidensmodellering & Digitalisering (Bodil Nistrup Madsen & Hanne Erdman Thomsen)
Vidensmodellering & Digitalisering (Bodil Nistrup Madsen & Hanne Erdman Thomsen)CBS Competitiveness Platform
 
Kick start your mobile project
Kick start your mobile projectKick start your mobile project
Kick start your mobile projectNexer Digital
 
Dangerous liaisons study showing that revolving door at sec creates risk of...
Dangerous liaisons   study showing that revolving door at sec creates risk of...Dangerous liaisons   study showing that revolving door at sec creates risk of...
Dangerous liaisons study showing that revolving door at sec creates risk of...Umesh Heendeniya
 
Predict The Future: Avoiding Failures with the Pre-Mortem
Predict The Future: Avoiding Failures with the Pre-MortemPredict The Future: Avoiding Failures with the Pre-Mortem
Predict The Future: Avoiding Failures with the Pre-MortemDan Corbin
 
This is Jane
This is JaneThis is Jane
This is JaneMartafy!
 
Agiles 2009 - Power Workshops: Kick-starting your Agile Project - Joke Vandem...
Agiles 2009 - Power Workshops: Kick-starting your Agile Project - Joke Vandem...Agiles 2009 - Power Workshops: Kick-starting your Agile Project - Joke Vandem...
Agiles 2009 - Power Workshops: Kick-starting your Agile Project - Joke Vandem...Agiles2009
 
Light Up October - Project Kick Off
Light Up October - Project Kick OffLight Up October - Project Kick Off
Light Up October - Project Kick Offlightupoctober
 
Project Fusion Engagement Kick-Off
Project Fusion Engagement Kick-OffProject Fusion Engagement Kick-Off
Project Fusion Engagement Kick-OffRalph Hatem
 
Kick-off meeting Insulated Cable Power
Kick-off meeting Insulated Cable Power Kick-off meeting Insulated Cable Power
Kick-off meeting Insulated Cable Power Aestikani Mahani
 
The End Of The Human Cannonball: Project Leadership In Today's World
The End Of The Human Cannonball: Project Leadership In Today's WorldThe End Of The Human Cannonball: Project Leadership In Today's World
The End Of The Human Cannonball: Project Leadership In Today's WorldBas de Baar
 

En vedette (20)

How To Land A Job In Product Management (Product Camp Summer 2016)
How To Land A Job In Product Management (Product Camp Summer 2016)How To Land A Job In Product Management (Product Camp Summer 2016)
How To Land A Job In Product Management (Product Camp Summer 2016)
 
Lesson from Most Captivating Presenter
Lesson from Most Captivating PresenterLesson from Most Captivating Presenter
Lesson from Most Captivating Presenter
 
Kickoff Meeting 2010
Kickoff Meeting 2010Kickoff Meeting 2010
Kickoff Meeting 2010
 
RENDER Telefonica
RENDER TelefonicaRENDER Telefonica
RENDER Telefonica
 
The Glass is Half FULL
The Glass is Half FULLThe Glass is Half FULL
The Glass is Half FULL
 
Out of the Fishbowl
Out of the FishbowlOut of the Fishbowl
Out of the Fishbowl
 
Implications of MIFIDII - The Regulator’s View (Alberto Garcia)
Implications of MIFIDII - The Regulator’s View (Alberto Garcia)Implications of MIFIDII - The Regulator’s View (Alberto Garcia)
Implications of MIFIDII - The Regulator’s View (Alberto Garcia)
 
The Next Generation of Immersive, Online Brand Building
The Next Generation of Immersive, Online Brand BuildingThe Next Generation of Immersive, Online Brand Building
The Next Generation of Immersive, Online Brand Building
 
UX Kick Start - Start Your Mobile Project Off On The Right Foot
UX Kick Start - Start Your Mobile Project Off On The Right FootUX Kick Start - Start Your Mobile Project Off On The Right Foot
UX Kick Start - Start Your Mobile Project Off On The Right Foot
 
Vidensmodellering & Digitalisering (Bodil Nistrup Madsen & Hanne Erdman Thomsen)
Vidensmodellering & Digitalisering (Bodil Nistrup Madsen & Hanne Erdman Thomsen)Vidensmodellering & Digitalisering (Bodil Nistrup Madsen & Hanne Erdman Thomsen)
Vidensmodellering & Digitalisering (Bodil Nistrup Madsen & Hanne Erdman Thomsen)
 
Kick start your mobile project
Kick start your mobile projectKick start your mobile project
Kick start your mobile project
 
Dangerous liaisons study showing that revolving door at sec creates risk of...
Dangerous liaisons   study showing that revolving door at sec creates risk of...Dangerous liaisons   study showing that revolving door at sec creates risk of...
Dangerous liaisons study showing that revolving door at sec creates risk of...
 
Predict The Future: Avoiding Failures with the Pre-Mortem
Predict The Future: Avoiding Failures with the Pre-MortemPredict The Future: Avoiding Failures with the Pre-Mortem
Predict The Future: Avoiding Failures with the Pre-Mortem
 
This is Jane
This is JaneThis is Jane
This is Jane
 
Agiles 2009 - Power Workshops: Kick-starting your Agile Project - Joke Vandem...
Agiles 2009 - Power Workshops: Kick-starting your Agile Project - Joke Vandem...Agiles 2009 - Power Workshops: Kick-starting your Agile Project - Joke Vandem...
Agiles 2009 - Power Workshops: Kick-starting your Agile Project - Joke Vandem...
 
Light Up October - Project Kick Off
Light Up October - Project Kick OffLight Up October - Project Kick Off
Light Up October - Project Kick Off
 
Project Fusion Engagement Kick-Off
Project Fusion Engagement Kick-OffProject Fusion Engagement Kick-Off
Project Fusion Engagement Kick-Off
 
MIFID 2
MIFID 2MIFID 2
MIFID 2
 
Kick-off meeting Insulated Cable Power
Kick-off meeting Insulated Cable Power Kick-off meeting Insulated Cable Power
Kick-off meeting Insulated Cable Power
 
The End Of The Human Cannonball: Project Leadership In Today's World
The End Of The Human Cannonball: Project Leadership In Today's WorldThe End Of The Human Cannonball: Project Leadership In Today's World
The End Of The Human Cannonball: Project Leadership In Today's World
 

Similaire à Learn more about Pharmalink

About Pharmalink
About PharmalinkAbout Pharmalink
About Pharmalinktemreez
 
About Pharmalink
About PharmalinkAbout Pharmalink
About PharmalinkKotoole
 
About Pharmalink
About PharmalinkAbout Pharmalink
About Pharmalinklquinlan
 
Quality assurance in the pharmaceutical industry
Quality assurance in the pharmaceutical industryQuality assurance in the pharmaceutical industry
Quality assurance in the pharmaceutical industryfatboysec
 
Raaj Global Pharma Regulatory Affairs Consultants Thane-mumbai profile-updat...
Raaj Global Pharma Regulatory Affairs  Consultants Thane-mumbai profile-updat...Raaj Global Pharma Regulatory Affairs  Consultants Thane-mumbai profile-updat...
Raaj Global Pharma Regulatory Affairs Consultants Thane-mumbai profile-updat...Rajashri Survase Ojha
 
Axsource overview Nov 2012
Axsource overview Nov 2012Axsource overview Nov 2012
Axsource overview Nov 2012Navneet Sekhon
 
Quality Auditor and trainerProfile-G.sundar
Quality Auditor and trainerProfile-G.sundarQuality Auditor and trainerProfile-G.sundar
Quality Auditor and trainerProfile-G.sundarG Sundar
 
Artixio MedTech Training Brochure 2023.pdf
Artixio MedTech Training Brochure 2023.pdfArtixio MedTech Training Brochure 2023.pdf
Artixio MedTech Training Brochure 2023.pdfY. Yogi Raj
 
Sai pharma consultants
Sai pharma consultantsSai pharma consultants
Sai pharma consultantsT Rama Rao
 
PAT and QbD concepts in designing the LiMS and other Electronic systems in La...
PAT and QbD concepts in designing the LiMS and other Electronic systems in La...PAT and QbD concepts in designing the LiMS and other Electronic systems in La...
PAT and QbD concepts in designing the LiMS and other Electronic systems in La...balakrishna t
 
Bilcare_GCS Quality and Regulatory Overiew
Bilcare_GCS Quality and Regulatory OveriewBilcare_GCS Quality and Regulatory Overiew
Bilcare_GCS Quality and Regulatory OveriewBilcare GCS
 
Pharma Regulatory & licensing Service
Pharma Regulatory & licensing ServicePharma Regulatory & licensing Service
Pharma Regulatory & licensing ServiceVikram sathish Asokan
 
Pharmacovigilance Inspections
Pharmacovigilance InspectionsPharmacovigilance Inspections
Pharmacovigilance InspectionsIFAH
 
Chempharm Profile Presentation
Chempharm Profile Presentation Chempharm Profile Presentation
Chempharm Profile Presentation CHUAN YAO
 
International Regulatory Overview 2009 Rev Linkedln
International Regulatory Overview   2009 Rev LinkedlnInternational Regulatory Overview   2009 Rev Linkedln
International Regulatory Overview 2009 Rev LinkedlnMdbio
 
Company_Brochure_for_Audit
Company_Brochure_for_AuditCompany_Brochure_for_Audit
Company_Brochure_for_AuditDivya Ganapathy
 
Sai pharma solutions inc scientific-regulatory affairs-qms and c gmp consult...
Sai pharma solutions inc  scientific-regulatory affairs-qms and c gmp consult...Sai pharma solutions inc  scientific-regulatory affairs-qms and c gmp consult...
Sai pharma solutions inc scientific-regulatory affairs-qms and c gmp consult...JRamniwas
 
Qa tools and techniques
Qa tools and techniquesQa tools and techniques
Qa tools and techniquesprashik shimpi
 

Similaire à Learn more about Pharmalink (20)

About Pharmalink
About PharmalinkAbout Pharmalink
About Pharmalink
 
About Pharmalink
About PharmalinkAbout Pharmalink
About Pharmalink
 
About Pharmalink
About PharmalinkAbout Pharmalink
About Pharmalink
 
Quality assurance in the pharmaceutical industry
Quality assurance in the pharmaceutical industryQuality assurance in the pharmaceutical industry
Quality assurance in the pharmaceutical industry
 
Raaj Global Pharma Regulatory Affairs Consultants Thane-mumbai profile-updat...
Raaj Global Pharma Regulatory Affairs  Consultants Thane-mumbai profile-updat...Raaj Global Pharma Regulatory Affairs  Consultants Thane-mumbai profile-updat...
Raaj Global Pharma Regulatory Affairs Consultants Thane-mumbai profile-updat...
 
Axsource overview Nov 2012
Axsource overview Nov 2012Axsource overview Nov 2012
Axsource overview Nov 2012
 
Quality Auditor and trainerProfile-G.sundar
Quality Auditor and trainerProfile-G.sundarQuality Auditor and trainerProfile-G.sundar
Quality Auditor and trainerProfile-G.sundar
 
Chempharm Profile Presentation
Chempharm Profile Presentation Chempharm Profile Presentation
Chempharm Profile Presentation
 
Artixio MedTech Training Brochure 2023.pdf
Artixio MedTech Training Brochure 2023.pdfArtixio MedTech Training Brochure 2023.pdf
Artixio MedTech Training Brochure 2023.pdf
 
Sai pharma consultants
Sai pharma consultantsSai pharma consultants
Sai pharma consultants
 
PAT and QbD concepts in designing the LiMS and other Electronic systems in La...
PAT and QbD concepts in designing the LiMS and other Electronic systems in La...PAT and QbD concepts in designing the LiMS and other Electronic systems in La...
PAT and QbD concepts in designing the LiMS and other Electronic systems in La...
 
Bilcare_GCS Quality and Regulatory Overiew
Bilcare_GCS Quality and Regulatory OveriewBilcare_GCS Quality and Regulatory Overiew
Bilcare_GCS Quality and Regulatory Overiew
 
Pharma Regulatory & licensing Service
Pharma Regulatory & licensing ServicePharma Regulatory & licensing Service
Pharma Regulatory & licensing Service
 
Pharmacovigilance Inspections
Pharmacovigilance InspectionsPharmacovigilance Inspections
Pharmacovigilance Inspections
 
Chempharm Profile Presentation
Chempharm Profile Presentation Chempharm Profile Presentation
Chempharm Profile Presentation
 
Prsg folder
Prsg folderPrsg folder
Prsg folder
 
International Regulatory Overview 2009 Rev Linkedln
International Regulatory Overview   2009 Rev LinkedlnInternational Regulatory Overview   2009 Rev Linkedln
International Regulatory Overview 2009 Rev Linkedln
 
Company_Brochure_for_Audit
Company_Brochure_for_AuditCompany_Brochure_for_Audit
Company_Brochure_for_Audit
 
Sai pharma solutions inc scientific-regulatory affairs-qms and c gmp consult...
Sai pharma solutions inc  scientific-regulatory affairs-qms and c gmp consult...Sai pharma solutions inc  scientific-regulatory affairs-qms and c gmp consult...
Sai pharma solutions inc scientific-regulatory affairs-qms and c gmp consult...
 
Qa tools and techniques
Qa tools and techniquesQa tools and techniques
Qa tools and techniques
 

Learn more about Pharmalink

  • 1. An Overview 2011 1
  • 2. Your presentation today Pharmalink  Profile & Capabilities Global Regulatory Experience Project Experience – Case Studies Additional Capabilities  Summary
  • 4. Who we are Founded in UK in 1998 Privately held Leading independent Regulatory Affairs  Specialist Offices in US, Europe, India and Asia‐Pacific 155 Staff as of January 2011 Large, proprietary network of freelance RA  professionals worldwide
  • 5. Who we work with 18 of top 20 healthcare companies  Large pharmaceutical multinationals Consumer Health organizations and divisions Biotechnology & new technology Clinical research organizations Medical device companies Generic companies Start‐up ventures Virtual companies
  • 6. Consumer Profile Pharma Biotech Medical device Consumer Health Veterinary Generics Nutraceuticals/Other
  • 8. What we can help with Small to large scale projects  Domestic, international and multinational  projects Short to long term projects Interim regulatory staffing needs Assistance at all stages of regulatory lifecycle
  • 9. What we can help with Non‐clinical Clinical Development D ru g Di Pre‐Submission Activity scov e ry Filing / Submission Approval Product Launch Post‐Approval
  • 10. RA Solutions that fit your business REGULATORY Regulatory Strategy Clinical Advertising &  Promotion/Labeling SERVICES Regulatory agency Preparation of meetings CTD Module 2 & 5 USPI/PLR/SPC/CDS Filing strategy Review of protocols & User testing Response to agency CSRs Packaging queries CTA preparation Advisory Committee Review of IBs preparation Regulatory Operations CMC & Manufacturing  IRB/EC documentation Scientific Advice Compliance Orphan indication CTD/eCTD/dossier  Lifecycle management preparation Pediatric development Gap analysis & remediation Input from Subject Matter plans Submission advice Experts Preparation of Amendments Translation service CTD Module 2 & 3  Medical writing Filing Expertise DMF preparation GCP audit Non‐clinical Validation IND/IMPD TPM site identification Original NDA/MAA Postmarketing Maintenance Preparation of Contract QP ANDA CTD Module 2 & 4 Import documentation and  sNDA/variations Review of toxicology &  BLA pharmacology studies licensing Annual  Reporting 510K/PMA GLP/GMP audit Postmarketing Commitments Pre‐approval inspections Safety reporting eg PSUR
  • 11. RA Solutions that fit your business A Regulatory Affairs team for all your regulatory needs Junior consultants to Subject Matter Experts  Generalists to specialists Assistance with projects of any scale and  length On‐site or remote working on Domestic,  International, and Multinational assignments
  • 12. How we work Project are served by appropriate experience – 1 yr to 30+ yr depending on requirements – Mainstream or specialized experienced – Industry and/or Agency expertise Senior Regulatory Managers assisted by  junior level staff for data intensive work
  • 14. Global experience Our consultants have experience in the  following regions: Europe (EU, Switzerland, Norway, Iceland) Middle East and Africa North America and Canada Central America and Caribbean Community Latin America Central & Eastern European states Australia & New Zealand
  • 15. Global Pharmalink Offices Cambridge, MA Short Hills, NJ King of Prussia, PA Maidenhead, UK Singapore San Francisco, CA Mumbai, India Hartford, CT Washington, DC New York, NY Durham, NC
  • 16. Pharmalink Affiliate Network LOCAL REGULATORY AFFAIRS WORLDWIDE
  • 17. Pharmalink Affiliate Network Access to local Regulatory Affairs expertise when and where  you need it. The best Regulatory Affairs professionals in every  continent. Covering every market from Argentina to Zambia. Leading local consultants who: – understand the culture – will ensure your requirements are met – save you time and money.
  • 18. Pharmalink Affiliate Network EUROPE AUSTRIA  |  BELGIUM  |  CYPRUS  |  CZECH REPUBLIC  |  DENMARK  | FINLAND FRANCE  |  GERMANY  |  GREECE  |  IRELAND  |  ITALY  |  NETHERLANDS PORTUGAL  |  SPAIN  |  SWEDEN  |  SWITZERLAND  |  TURKEY |  UK (GLOBAL HQ)
  • 20. Pharmalink Affiliate Network AFRICA ANGOLA  |  BOTSWANA  |  DEMOCRATIC REPUBLIC OF CONGO  |  LESOTHO MADAGASCAR  |  MALAWI  |  MAURITIUS  |  MOZAMBIQUE NAMIBIA | SOUTH AFRICA  |  SWAZILAND  |  TANZANIA  |  ZAMBIA  |  ZIMBABWE
  • 21. Pharmalink Affiliate Network EASTERN EUROPE ALBANIA  |  AZERBAIJAN  |  BOSNIA & HERZEGOVINA  |  BULGARIA  |  CROATIA ESTONIA  |  GEORGIA  |  HUNGARY  |  KAZAKHSTAN KOSOVO  |  MACEDONIA  |  MOLDOVA  |  MONTENEGRO  |  POLAND  |  ROMANIA RUSSIA  |  SERBIA  |  SLOVAKIA  |  SLOVENIA  |  UKRAINE  |  UZBEKISTAN
  • 22. Pharmalink Affiliate Network ASIA PAC AUSTRALIA  |  CHINA  |  HONG KONG  |  INDIA JAPAN  |  MALAYSIA  |  NEW ZEALAND  |  PHILIPPINES  |  SINGAPORE SOUTH KOREA  |  THAILAND
  • 23. Pharmalink Affiliate Network NORTH AMERICA CANADA UNITED STATES:  NJ (US HQ) |  MA  |  CT  |  NY  |  PA  |  NC  |  CA  |  DC
  • 24. Pharmalink Affiliate Network ARGENTINA  |  ARUBA  |  BELIZE  |  BRAZIL  |  CHILE  |  COLOMBIA |  COSTA RICA DOMINICAN REPUBLIC  |  ECUADOR  |  EL SALVADOR  |  GUATEMALA HONDURAS  |  JAMAICA  |  MEXICO  |  NICARAGUA PANAMA  |  PARAGUAY  |  PERU  |  PUERTO RICO  |  TRINIDAD  |  VENEZUELA
  • 26. Case Study 1 Major regulatory compliance project CLIENT A major pharmaceutical company based in Europe. PROJECT A large compliance project. OBJECTIVE Review all European‐registered licenses and bring into  compliance with current manufacturing site practices. SOLUTION Pharmalink provided a dedicated team of regulatory affairs  specialists to work on the project for 3 years. One of the key advantages that Pharmalink was able to bring to the  project was the ability to adjust the number of consultants working on   the project to fit the client’s needs and hit every deadline whilst  always maintaining the level of quality.
  • 27. Case Study 1 Project Details Consultants reviewed registered details against manufacturing site  documents, highlighting compliance issues. Consultants worked with site QA departments in preparing  remediation plans for each license. Over 600 licenses were reviewed and each phase of the project  was delivered to the client’s timelines. Pharmalink’s staff exceeded the client’s expectations on each  phase of the defined project, resulting in the client engaging  Pharmalink to prepare all of the Variations and submit to all EU agencies in order to bring the product licenses into compliance.
  • 28. Case Study 2 Biosimilar Product Review CLIENT A major pharmaceutical company based in Europe. PROJECT Review and update of a Module 3 and Quality Overall  Summary for a Biosimilar product in preparation for one of  the first European submissions of its type. OBJECTIVE Document submission. Speed to market was of high priority to the client. SOLUTION Pharmalink  was able to turn to one of its experienced  consultants with a track record specifically with the biotech  product in question.
  • 29. Case Study 2 Project Details The consultant reviewed and updated submission documents and  provided a pragmatic corrective action listing whilst preparing key parts of  the filing. The consultant added value by preparing a risk analysis alongside the  required output, thus ensuring that the client was aware of potential  issues once the filing was undertaken. Work delivered to the client less than a month after the documents were  received by Pharmalink. Pharmalink completed the task by reviewing the project with the client,  providing an online facility to feedback on the experience and ensure a  satisfactory service, at no cost to the client. The client submitted the documentation with understanding of the road ahead.
  • 30. Case Study 3 Multinational clinical trial sponsor & Clinical  Research Organization CLIENT Sponsor and CRO. PROJECT Provide regulatory support for a clinical trial including new  submissions for the trial in multiple markets. OBJECTIVE Submit the clinical trial in multiple locations in a timely  manner to allow trial initiation. SOLUTION Pharmalink provided consultants with valuable local  knowledge to add to the regulatory intelligence of submissions  in each market. This project was a testament to the lengths to which the team went to understand the brief and work with the client to achieve their goals.
  • 31. Case Study 3 Project Details Multinational program ‐ 9 markets – Europe  FR, UK, DE, PL – Eastern Europe Russia, Ukraine – Middle East  Egypt, Israel – Asia  India The challenge was to guide a US‐based sponsor through the  regulatory procedures and processes, different in all markets,  whilst work with multiple vendors in areas such as safety  reporting, ethics submissions and so forth. Pharmalink fulfilled the requirements and submissions completed  to date have been filed according to the planned schedule.
  • 32. Case Study 4 Global Product Compliance Project Large Pharmaceutical Company CLIENT Top 10 Pharma Company. PROJECT Since 2004, Pharmalink Consulting have been successfully  performing a large‐scale Global Quality Compliance program for a  company, covering approximately 1400 Quality Dossiers  worldwide. OBJECTIVE Short term – get product moving around Europe again. Long term  – bring all dossiers and licenses up to date providing  sustainable compliance. SOLUTION The team that Pharmalink Consulting assembled has successfully  driven all key stages of the compliance process including: – Quality Dossier collection and collation into CTD format – CMC Compliance Assessment – Product Remediation
  • 33. Case Study 4 Project Details Dossiers Collected 270 Dossiers Collated 270 Compliance Assessments Performed 270 (10% TPM) Remediation Packages Prepared 564 Markets AT, BE, BU, CH, CY, CZ, DE, DK, EE, EL,ES, FI, FR, HU, IE, IS,  IT, LT,    LV, MT, NL, NO,  PL, PO, RO, SE, SK, UK
  • 34. Case Study 4 Project Details Throughout the compliance project in Europe, the Company was forced to  halt product shipment until gap analysis was completed. This put enormous pressure on the team, yet the impact on product shipments  remained minimal. Various stages of the compliance process were performed remotely from  the client, across the Pharmalink offices in North America, Europe and  Asia. All objectives and milestones were successfully achieved ahead of  target dates. The Pharmalink team reached 45 in number at the height of the activity  but remained flexible dependent on the workload so were able to adjust  accordingly. Pharmalink was able to offer office facilities for the purposes  of the project. The resulting completion of the European section of the project meant a  satisfied client who has continued to employ Pharmalink for regulatory  activities across multiple sites in Europe and the United States.
  • 36. Permanent Staffing Pharmalink Consulting, the regulatory affairs  specialists since 1998, introduces a unique  regulatory recruitment solution Pharmalink has unrivalled access to permanent  regulatory affairs candidates throughout the industry. All of our candidates have been interviewed by Senior  Regulatory Affairs professionals familiar with client  needs. We can offer optional interim staffing by one of our  regulatory affairs consultants while we identify your ideal permanent employee.
  • 37. Permanent Staffing The Pharmalink Permanent Solution 6 Step Plan STEP 1 STEP 2 STEP 3 STEP 4 STEP 5 STEP 6 [optional] You Contact  Pharmalink  We research  Pharmalink Following  identify a Pharmalink,  can provide  our  provides a  selection,  permanent where an  an  extensive  selection of  your new  recruitment experienced  experienced  portfolio of  chosen  member need regulatory  consultant to  regulatory  candidates  of staff  affairs   act as an  affairs  for you to  commences  professional interim  professionals meet and  role will discuss member who have  consider your  of staff while previously  requirement we identify  been  and take a  your ideal  screened and  detailed brief permanent  vetted  employee
  • 38. What else can we offer you? Resource backup and alternative, flexible  ways of working from regional hubs Local knowledge on a global scale High Quality Translation Service in 100+  Languages A company accredited with QMS ISO 9001 A company accredited with IIP status Recently completed a $2.4 million investment  program Electronic publishing ‐ eSubmissions
  • 40. Our offering in summary 1. We have demonstrable capability and  experience with large scale multi‐product,  multi‐national regulatory projects on  behalf of Top‐20 healthcare companies. Our familiarity with such sizeable projects  provides our clients with assurance that  the desired results can be achieved for any  project of any size.
  • 41. Our offering in summary 2. Our global regulatory teams are comprised  of consultants with a wide range of skills  and levels of experience. This allows us to be able to meet client  requirements while ensuring that costs are  kept to a minimum by using the right level  of consultant for the various tasks.
  • 42. Our offering in summary 3. The infrastructure, both in terms of systems  and people, that we have established and in  which we have invested, underpins our  ability to undertake projects of varying  scale. We have a purpose‐built, centrally‐managed  IT network for all of our offices worldwide.  This will ensure peace of mind as we are able  to segregate and secure individual company  data while allowing for flexible access.
  • 43. Our offering in summary 4. Whilst Pharmalink Consulting is now a  multi‐national consultancy that is  recognized as a global leader in Regulatory  Affairs, we remain nimble and flexible to  react to our clients’ often urgent  requirements.
  • 44. Thank you USA:  + 1 800 434 5808 SHORT HILLS, NJ   |   CAMBRIDGE, MA   |   HARTFORD, CT   |   MANHATTAN, NY   |   KING OF PRUSSIA, PA DURHAM, NC   |   SAN FRANCISCO, CA   |   WASHINGTON, DC  UK:  + 44 1628 860300 MAIDENHEAD, BERKSHIRE INDIA:  + 91 22 4030 9595 MUMBAI SINGAPORE:  + 65 6408 0515